Search

everythinglearnresearchcommunity

for

Search:↓

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Gender identity can be more diverse than just male or female.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

Sex hormones, especially androgens, play a key role in causing acne.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Men and women react differently to opioids, with hormones potentially influencing these differences.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Hormonal therapy in adults with gender dysphoria often leads to skin issues like acne, requiring a team of skin and hormone doctors.

Adults with gender dysphoria on hormone treatment often have skin problems like acne, which are common but not always recognized.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Most insurance companies do not cover extra gender-affirming surgeries, with coverage being low and inconsistent.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.